Stock Market News for March 6, 2026
331 news published.
Quarterly and full‑year financials
TEN, Ltd. (TEN) reported profits for the twelve months and Q4 ended Dec. 31, 2025, reinforcing that select industrials and specialty manufacturers are closing the year with positive operating momentum—watch margins and working‑capital trends for forward guidance.
Immuneering (IMRX) reported Q4 and full‑year 2025 results, updating investors on cash runway and R&D spend—key metrics for small‑cap biotech valuation ahead of upcoming trial readouts.
PMV Pharmaceuticals (PMVP) released its full‑year 2025 results and corporate highlights, giving context on commercialization milestones and near‑term capital needs ahead of partnership talks.
InMed (INM) provided an update on BayMedica operations and its focus on the pharmaceutical development pipeline, a strategic shift that investors should interpret as prioritization of higher‑value, late‑stage assets and potential capital redeployment.
Major regulatory approvals and clinical milestones
Halozyme Therapeutics (HALO) won FDA approval for TECVAYLI® with DARZALEX FASPRO® in relapsed/refractory multiple myeloma—an expanded label that can accelerate revenue and broaden partnership options for biologics manufacturers.
Lantheus (LNTH) received FDA approval for PYLARIFY TruVu™ (piflufolastat F 18), a commercial milestone that should boost imaging revenue and strengthen the company’s diagnostics positioning.
Blackbone Therapeutics (BBOT) announced a publication in Cancer Discovery showing preclinical data for BBO‑11818, a pan‑KRAS inhibitor—peer‑reviewed data that can de‑risk partnerships and licensing conversations.
Incyte (INCY) secured European Commission approval for Zynyz® (retifanlimab) as first‑line treatment for advanced squamous cell carcinoma of the anal canal, a regulatory win that expands the drug’s commercial footprint in oncology and could meaningfully lift European sales forecasts.
TG Therapeutics (TGTX) outlined its AAN 2026 data presentations for BRIUMVI®, a calendar event that may swing sentiment in immunology and MS mid‑caps.
Capital raises, restructurings and M&A
Solid Biosciences (SLDB) closed an oversubscribed $240 million private placement, reducing near‑term financing risk for the clinical‑stage developer.
Star Bulk Carriers (SBLK) agreed to acquire 16 vessels from Diana Shipping, while Genco Shipping & Trading (GNK) responded to a revised unsolicited proposal from Diana, keeping shipping consolidation and counteroffer risk front and center for cyclical freight names.
Blue Moon (BMM) provided an update on financing and engagement of Outside the Box Capital, a funding step investors will watch for runway clarity.
Debt moves, buybacks and capital allocation
Honeywell (HON) launched tender offers to buy up to $3.75 billion (USD) and up to €1.25 billion (EUR) of securities, a sizable capital‑structure action that can recalibrate leverage, interest expense and near‑term EPS dynamics.
Prenetics (PRE) authorized a $40 million share repurchase program, signaling management confidence and potential float reduction.
Blue Owl Capital Corporation II (OWL) confirmed receipt of an unsolicited minority tender offer from Cox and Saba at a discount to NAV, a development that could pressure valuation and force board responses on shareholder value.
Listings, uplistings and market access
MiniMed (MDT) began trading on the Nasdaq Global Select Market, improving market access and potential liquidity for the medical‑device spin‑out.
Virtuix (VTIX) rang the Nasdaq closing bell after listing on the Nasdaq Global Market—an event that can measurably improve liquidity and retail discovery.
Powell Industries (POWL) announced a three‑for‑one stock split, a shareholder‑friendly move that typically improves retail accessibility without changing fundamentals.
United States Antimony (UAMY) announced an uplisting to the NYSE, broadening institutional access for the mining play.
Strategic partnerships, media tie‑ups and consumer moves
DraftKings (DKNG) and ESPN detailed plans to provide account linking for customers, a distribution and engagement play that may lift user acquisition and cross‑sell efficiency for sportsbooks and media‑adjacent betting businesses.
Nuvve (NVVE) partnered with OMNIA Global on a 1GW development pipeline, including a 50MW/75MWh battery energy‑storage system in Sweden—a concrete step toward recurring revenue from grid services and V2G.
American Resources (AREC) said its Electrified Materials unit is expanding processing capacity to scale domestic circular supply chains for rare earths—an onshoring play aligned with policy tailwinds.
Strategic partnerships, energy, quantum and defense wins
TotalEnergies (TTE) published an independent assessment of the land acquisition program for the Tilenga project in Uganda, a disclosure relevant to project execution risk and ESG oversight on large energy investments.
Ondas (ONDS) won new orders for counter‑drone systems from Middle East customers, highlighting recurring defense electronics contract potential.
Xanadu (CHAC) secured a $2.0 million ARPA‑E grant to advance a quantum platform for next‑generation batteries, linking deep‑tech R&D to energy‑storage innovation.
Capital markets innovation and crypto access
21Shares (TXXS) launched a Polkadot ETF (TDOT) in the U.S., adding institutional‑grade access to a major smart‑contract token and underscoring continued ETF expansion in digital assets.
Krown Network (QNC) and Quantum eMotion deployed a quantum‑secure infrastructure protecting $67.5 million in KROWN tokens—an operational milestone for crypto custody and security narratives.
Strategic partnerships and product rollouts
Snail, Inc. (SNAL) said its Bellwright unit surpassed 1 million units sold ahead of a full 1.0 launch, signaling product traction and potential monetization scale for a consumer gaming/IP play.
Governance, legal and market‑structure updates
Ashford Hospitality Trust (AHT) announced the planned retirement of CFO Deric Eubanks, a management change that investors will watch for continuity in capital allocation and reporting cadence.
JM Group Limited (JMG) provided an update on its trading halt, a development that can affect liquidity until normal trading resumes.
Klarna Group (KLAR) clarified the mechanics of its March 9 lock‑up expiration, an item investors track for potential insider selling and secondary supply dynamics.
Alpha Modus (AMOD) secured a settlement in its AI retail‑technology patent enforcement, potentially converting legal exposure into royalties or licensing clarity.
Restaurant Brands International (QSR) recommended that shareholders reject NYSB's "mini‑tender offer", a defensive stance that helps limit opportunistic short‑form purchases and potential dilution ahead of any strategic review.
Shopify (SHOP) disclosed automatic securities disposition plans adopted by its CEO, a routine disclosure investors should parse for timing and potential impact on near‑term insider selling flows.
Travel and passenger trends
Grupo Aeroportuario del Pacífico (PAC) reported a 5.5% year‑over‑year decrease in passenger traffic for February 2026, a near‑term demand signal that could weigh on airport revenues and airport‑linked concessions in the region if the trend continues.
Listings, compliance and exchange notices
Some small‑cap and growth names are managing listing thresholds: Aptorum Group (APM) and DeFi Technologies (DEFT) each received Nasdaq notification letters regarding minimum bid price deficiencies, a procedural step that can lead to compliance plans or, if unresolved, delisting risk investors should monitor.
Nerdy (NRDY) also announced receipt of a notice from the NYSE, another reminder that listing standards remain a gating factor for some growth‑stage firms.
Investor materials and coverage
Gaming and Leisure Properties (GLPI) released a new investor presentation, useful for REIT and yield‑focused investors re‑assessing portfolio exposure and payout sustainability.
Stonegate updated coverage on NCS Multistage (NCSM), a note that can guide short‑term analyst views on 2025 Q4 results and equipment demand.
Smaller but notable items
- Silynxcom (SYNX) received an over $620,000 tactical systems order from a Middle East customer—modest revenue but relevant for defense‑electronics exposure.
- Mangoceuticals (MGRX) announced a PCT patent filing for MGX‑0024 antiviral technology, extending potential IP protection for its early‑stage antiviral assets.
- Harvard Bioscience (HBIO) and Wearable Devices Ltd. (WLDS) each announced reverse stock splits and a 1‑for‑3 reverse split, typical governance steps to regain listing compliance or adjust float.
- Crescent Biopharma (CBIO) announced grants of inducement awards, a hiring‑and‑retention action that can help stabilize management as the company advances programs.
Why this matters to investors
- Major regulatory wins (Incyte, Halozyme, Lantheus) directly affect revenue trajectories and partnership leverage for biotech and diagnostics investors.
- Capital actions and M&A chatter (Honeywell tenders, Star Bulk/Diana/Genco) change leverage and valuation dynamics across industrial and shipping sectors.
- Passenger trends and travel metrics (Grupo Aeroportuario) offer early signs of consumer demand shifts that influence airport, airline and travel‑service forecasts.
- Compliance notices and listing risks (Aptorum, DeFi Technologies, Nerdy) are reminders that exchange standards can be binary catalysts for small‑cap volatility.
- Corporate governance moves (RBI’s mini‑tender defense, Shopify CEO plan) alter supply dynamics and can be catalysts for short‑term price action.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement